Funding the Global Response

The ACT-Accelerator, the major global multi-lateral initiative coordinating pandemic response, has requested $16.8 billion in grant funding to support activities from October 2021 to September 2022. More than halfway through its budget year, ACT-A has raised less than $3 billion, a fraction of the funding needed to implement its strategy. At 18% funded, the vaccines pillar fares best ($1,050 million), while only $6.5 million has been allocated to the diagnostics pillar, less than 1% of the target funding. The persistent lack of funding may be indicative of waning support among wealthier countries for the “no one is safe until everyone is safe” approach.

Source: WHO, updated April 22, 2022
NOTE: These funding targets (tracked at the source listed above) are set for donor countries and differ from those in the ACT-A Strategic Plan, which include expected contributions from development banks and self-funding middle-income countries.

In February, the ACT-Accelerator Facilitation Council’s Finance and Resource Mobilization Working Group, chaired by Norway, set out a “fair share” framework to set contribution benchmarks by country. The calculation of the fair share benchmarks is based on the size of national economies and likely gains from a faster recovery of the global economy and trade. No country has yet come close to their fair share ask for the 2021-2022 budget year.

Fair Share Ask: G20 Countries

Source: WHO, updated April 22, 2022

Fair Share Ask: EU Countries

Source: WHO, updated April 22, 2022